All News

December 30, 2024

Delcath Systems Announces Additional $16.3 Million in Funding From Series E and E1 Warrant Exercises

December 30, 2024

RenovoRx Continues to Grow Intellectual Property Portfolio for its Novel Drug-Delivery Therapy Platform

December 27, 2024

TEVIMBRA Approved in U.S. for First-line Treatment of Gastric and Gastroesophageal Junction Cancers in Combination with Chemotherapy

December 27, 2024

Louis J. Cohen, P.C., Announces $15 Million Settlement of Medicare and Medi-Cal Fraud Kickback and Stark Law Violations against Former Physician Mohammad Rasekhi, Sheila Busheri, and Southern California Medical Center

December 27, 2024

Exicure, Inc. Partners with GPCR Therapeutics to Fuel New Growth in Biotech

December 26, 2024

M-Files Recognized in 2024 Gartner® Magic Quadrant™ for Document Management and Gartner® Critical Capabilities for Document Management

December 26, 2024

Digital Wave Technology Named a “Vendor to Watch” in the IDC MarketScape: Worldwide Retail Promotions Management, 2024-2025 Vendor Assessment

December 26, 2024

The Arena Group Receives Notice Accepting Plan to Regain Compliance with Continued Listing Standards

December 24, 2024

SOLVD Health Receives New York State Laboratory Approval

December 24, 2024

OS Therapies Announces Pricing of $6 Million Private Placement

December 23, 2024

Varex Announces Closing of Private Offering of $125 Million of Senior Secured Notes

December 23, 2024

Puma Biotechnology’s NERLYNX® Included in NCCN Clinical Practice Guidelines for the Treatment of Cervical Cancer with a HER2 Mutation

Business & Leadership